| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |